2025-09-03

Korean Patent Granted for CAR-Treg Therapy

2025-08-04

PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007

2025-07-31

PolTREG Secures Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial

2025-07-29

PolTREG’s Pharmaceutical Manufacturing Facility Now GMP Certified

2025-07-04

World-Class Experts Join Immuthera’s Scientific Advisory Board

2025-06-20

PolTREG at  BIO International Convention 2025

2025-06-13

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy

2025-05-14

PolTREG Q1 2025 financial results webinar